Home/Publication/Merck Backs Biotech Startup in NZ
Merck Backs Biotech Startup in NZ 

13 Oct 2026

US$ 20.00

Germany-based Merck KGaA, through its corporate venture arm, M Ventures, has led the NZ$12.8 m (US$7.3 m) seed funding...

Price / article: US$20.00
OR existing subscriber
Related Publications

APER Nov 2026 - The Legend Snaps...

Subscribers’ Weekly for the week ending 30th Oct 2026...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.